Project Number 5R01AG068319-03 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for DIAN-TU: Tau Next Generation Prevention Trial Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 8. Late-stage Clinical Drug Development (Phase II/III and III Clinical Trials) b. Tau Researcher and Organization Principal Investigator BATEMAN, RANDALL J Principal Investigator First Name RANDALL Principal Investigator Last Name BATEMAN Awardee Organization WASHINGTON UNIVERSITY IN SAINT LOUIS Awardee State Missouri Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-878: Late Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Required) FY Overall Cost $16,720,909 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
